JP2013155188A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013155188A5 JP2013155188A5 JP2013085785A JP2013085785A JP2013155188A5 JP 2013155188 A5 JP2013155188 A5 JP 2013155188A5 JP 2013085785 A JP2013085785 A JP 2013085785A JP 2013085785 A JP2013085785 A JP 2013085785A JP 2013155188 A5 JP2013155188 A5 JP 2013155188A5
- Authority
- JP
- Japan
- Prior art keywords
- dalbavancin
- amount
- dose
- bacterial infection
- single doses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960002488 dalbavancin Drugs 0.000 claims 4
- 108700009376 dalbavancin Proteins 0.000 claims 4
- KGPGQDLTDHGEGT-JCIKCJKQSA-N zeven Chemical compound C=1C([C@@H]2C(=O)N[C@H](C(N[C@H](C3=CC(O)=C4)C(=O)NCCCN(C)C)=O)[C@H](O)C5=CC=C(C(=C5)Cl)OC=5C=C6C=C(C=5O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@H](O5)C(O)=O)NC(=O)CCCCCCCCC(C)C)OC5=CC=C(C=C5)C[C@@H]5C(=O)N[C@H](C(N[C@H]6C(=O)N2)=O)C=2C(Cl)=C(O)C=C(C=2)OC=2C(O)=CC=C(C=2)[C@H](C(N5)=O)NC)=CC=C(O)C=1C3=C4O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O KGPGQDLTDHGEGT-JCIKCJKQSA-N 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42765402P | 2002-11-18 | 2002-11-18 | |
| US60/427,654 | 2002-11-18 | ||
| US48569403P | 2003-07-08 | 2003-07-08 | |
| US60/485,694 | 2003-07-08 | ||
| US49504803P | 2003-08-13 | 2003-08-13 | |
| US60/495,048 | 2003-08-13 | ||
| US49648303P | 2003-08-19 | 2003-08-19 | |
| US60/496,483 | 2003-08-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011083790A Division JP2011157381A (ja) | 2002-11-18 | 2011-04-05 | 細菌感染の治療のためのダルババンシンの投与方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013155188A JP2013155188A (ja) | 2013-08-15 |
| JP2013155188A5 true JP2013155188A5 (OSRAM) | 2014-05-15 |
Family
ID=32330046
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004570384A Expired - Lifetime JP5519090B2 (ja) | 2002-11-18 | 2003-11-14 | 細菌感染の治療のためのダルババンシンの投与方法 |
| JP2011083790A Pending JP2011157381A (ja) | 2002-11-18 | 2011-04-05 | 細菌感染の治療のためのダルババンシンの投与方法 |
| JP2013085785A Pending JP2013155188A (ja) | 2002-11-18 | 2013-04-16 | 細菌感染の治療のためのダルババンシンの投与方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004570384A Expired - Lifetime JP5519090B2 (ja) | 2002-11-18 | 2003-11-14 | 細菌感染の治療のためのダルババンシンの投与方法 |
| JP2011083790A Pending JP2011157381A (ja) | 2002-11-18 | 2011-04-05 | 細菌感染の治療のためのダルババンシンの投与方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (12) | US6900175B2 (OSRAM) |
| EP (1) | EP1565201B1 (OSRAM) |
| JP (3) | JP5519090B2 (OSRAM) |
| KR (2) | KR101173310B1 (OSRAM) |
| AU (3) | AU2003299561A1 (OSRAM) |
| CA (1) | CA2506236C (OSRAM) |
| DK (1) | DK1565201T3 (OSRAM) |
| ES (1) | ES2712656T3 (OSRAM) |
| HU (1) | HUE041133T2 (OSRAM) |
| IL (3) | IL168327A (OSRAM) |
| MX (1) | MXPA05005338A (OSRAM) |
| NO (1) | NO20052362L (OSRAM) |
| PT (1) | PT1565201T (OSRAM) |
| WO (3) | WO2004045637A1 (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060074014A1 (en) * | 2002-11-18 | 2006-04-06 | Vicuron Pharmaceuticals Inc. | Dalbavancin compositions for treatment of bacterial infections |
| US7119061B2 (en) * | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| DK1565201T3 (en) * | 2002-11-18 | 2019-02-25 | Vicuron Pharmaceuticals Llc | METHODS OF ADMINISTRATING DALBAVANCIN TO TREAT Bacterial Infections |
| US20090062182A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched dalbavancin |
| US8389583B2 (en) * | 2008-05-23 | 2013-03-05 | Zurex Pharma, Inc. | Antimicrobial compositions and methods of use |
| US20110132607A1 (en) * | 2009-12-07 | 2011-06-09 | Schlumberger Technology Corporation | Apparatus and Technique to Communicate With a Tubing-Conveyed Perforating Gun |
| CA2904387C (en) | 2013-03-15 | 2021-12-07 | Melinta Therapeutics, Inc. | Methods of treating infections in overweight and obese patients using antibiotics |
| CN105814352B (zh) | 2013-12-19 | 2019-01-04 | 通用电气健康护理生物科学股份公司 | 用于生物液体加工系统的远程促动阀 |
| WO2016011245A1 (en) | 2014-07-17 | 2016-01-21 | The Medicines Company | High purity oritavancin and method of producing same |
| CN107073072B (zh) | 2014-11-06 | 2021-06-18 | 埃克斯利亚制药有限公司 | 糖肽组合物 |
| KR102091852B1 (ko) * | 2015-03-02 | 2020-03-23 | 코로나리콘셉츠 엘엘씨 | Peg 대사산물 및 peg 분해 생성물 검정을 위한 화합물 및 방법 |
| JP6983660B2 (ja) | 2015-05-08 | 2021-12-17 | スペクトラル プラットフォームス インコーポレイテッド | アルブミンに基づく非共有結合性複合体およびその使用方法 |
| US20200171124A1 (en) | 2016-04-15 | 2020-06-04 | Lupin Limited | Topical compositions for ophthalmic and otic use |
| EP3602065A4 (en) | 2017-03-20 | 2020-12-23 | Spectral Platforms, Inc. | SPECTROSCOPIC METHODS OF DETECTION AND CHARACTERIZATION OF MICROORGANISMS |
| AU2018300062A1 (en) * | 2017-07-10 | 2020-01-30 | Contrafect Corporation | Blood component potentiation of lytic protein anti-bacterial activity and methods and uses thereof |
| CN110183519B (zh) * | 2019-05-06 | 2023-04-11 | 大邦(湖南)生物制药有限公司 | 一种达巴万星关键中间体a40926的分离纯化方法 |
| CN112480214B (zh) * | 2020-12-14 | 2023-03-28 | 成都雅途生物技术有限公司 | 一种达巴万星关键中间体a40926的制备方法 |
| EP4014965A1 (en) * | 2020-12-16 | 2022-06-22 | EVER Valinject GmbH | Aqueous solution |
| US20240083950A1 (en) | 2021-01-11 | 2024-03-14 | Xellia Pharmaceuticals Aps | Synthesis process |
| CN115215926A (zh) * | 2022-08-12 | 2022-10-21 | 丽珠集团福州福兴医药有限公司 | 达巴万星母核及其纯化方法、达巴万星及其合成方法 |
| UY40481A (es) * | 2022-10-12 | 2024-04-30 | Hikma Pharmaceuticals Usa Inc | Composición líquida de dalbavancina |
| UY40482A (es) | 2022-10-12 | 2024-04-30 | Hikma Pharmaceuticals Usa Inc | Composición líquida de dalbavancina. |
| EP4431084A1 (en) | 2023-03-16 | 2024-09-18 | Adalvo Limited | Formulation of dalbavancin |
| EP4431083A1 (en) | 2023-03-16 | 2024-09-18 | Adalvo Limited | Formulation of dalbavancin |
| WO2025158262A1 (en) | 2024-01-23 | 2025-07-31 | Lupin Limited | Stable pharmaceutical compositions of dalbavancin as ready-to-dilute formulation |
| GB202405996D0 (en) * | 2024-04-29 | 2024-06-12 | Arecor Ltd | Novel compositions |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US573679A (en) * | 1896-12-22 | Apparatus for mowing hay | ||
| US541616A (en) * | 1895-06-25 | Elevator attachment | ||
| GB1496386A (en) * | 1975-03-05 | 1977-12-30 | Lepetit Spa | Antibiotics |
| US4195079A (en) * | 1979-01-31 | 1980-03-25 | Pfizer Inc. | New polycyclic ether antibiotic |
| CA1183789A (en) | 1981-08-04 | 1985-03-12 | Kiyoshi Isono | Antibiotic 76-11, process for the production thereof, anticoccidiosis agent and domestic animals growth accelerator comprising the same as an effective ingredient |
| US4578271A (en) | 1982-05-24 | 1986-03-25 | Fujisawa Pharmaceutical Co., Ltd. | Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions |
| FI73697C (fi) * | 1982-06-08 | 1987-11-09 | Lepetit Spa | Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2. |
| FR2548021B1 (fr) | 1983-06-29 | 1986-02-28 | Dick P R | Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels |
| GB8415092D0 (en) * | 1984-06-13 | 1984-07-18 | Lepetit Spa | Ester derivatives |
| GB8425685D0 (en) | 1984-10-11 | 1984-11-14 | Lepetit Spa | Antibiotic a 40926 complex |
| US4914187A (en) * | 1984-11-13 | 1990-04-03 | Gruppo Lepetit S.P.A | Ester derivatives of antibiotic L 17046 |
| GB8428619D0 (en) * | 1984-11-13 | 1984-12-19 | Lepetit Spa | Derivatives of antibiotic l 17046 |
| GB8512795D0 (en) | 1985-05-21 | 1985-06-26 | Lepetit Spa | Increasing ratio of components of teicoplanin a2 complex |
| GB8531846D0 (en) | 1985-12-30 | 1986-02-05 | Lepetit Spa | Antibiotic a 40926 mannosyl aglycon |
| GB8608809D0 (en) | 1986-04-11 | 1986-05-14 | Lepetit Spa | Antibiotic |
| GB8621912D0 (en) | 1986-09-11 | 1986-10-15 | Lepetit Spa | Increasing ratio of components of anti-biotic complex |
| GB8621911D0 (en) * | 1986-09-11 | 1986-10-15 | Lepetit Spa | Increasing ratio of components of anti-biotic complex |
| GR871488B (en) | 1986-10-10 | 1987-11-12 | Lepetit Spa | New antibiotics |
| GB8715735D0 (en) * | 1987-07-03 | 1987-08-12 | Lepetit Spa | De-mannosyl teicoplanin derivatives |
| US4882313A (en) | 1987-07-31 | 1989-11-21 | Smithkline Beckman Corporation | Carboxamide derivatives of glycopeptides |
| GB8726859D0 (en) | 1987-11-17 | 1987-12-23 | Lepetit Spa | 22-dechlorotei-coplanins |
| US5004605A (en) * | 1987-12-10 | 1991-04-02 | Cetus Corporation | Low pH pharmaceutical compositions of recombinant β-interferon |
| FR2628269B1 (fr) * | 1988-03-04 | 1990-07-27 | Sgs Thomson Microelectronics | Dispositif de demarrage progressif d'une alimentation a decoupage |
| EP0376041B1 (en) | 1988-12-27 | 1996-02-28 | GRUPPO LEPETIT S.p.A. | C63-Amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanins |
| IE64155B1 (en) | 1989-03-29 | 1995-07-12 | Lepetit Spa | New substituted alkylamide derivatives of teicoplanin |
| JPH03193735A (ja) * | 1989-12-22 | 1991-08-23 | Shionogi & Co Ltd | グリコペプチド系抗生物質の安定化組成物 |
| US5030619A (en) * | 1990-04-16 | 1991-07-09 | Miles Inc. | Synergistic fungicidal composition |
| US5606036A (en) * | 1991-03-27 | 1997-02-25 | Gruppo Lepetit Spa | Antibiotic A 40926 ester derivatives |
| JP2783722B2 (ja) * | 1991-07-12 | 1998-08-06 | 麒麟麦酒株式会社 | スピカマイシン誘導体およびそれを含む抗腫瘍剤 |
| JP3418762B2 (ja) | 1991-07-29 | 2003-06-23 | バイオサーチ・イタリア・ソチエタ・ペル・アチオニ | 抗生物質ａ４０９２６のアミド誘導体類 |
| US5750509A (en) * | 1991-07-29 | 1998-05-12 | Gruppo Lepetit S.P.A. | Amide derivatives of antibiotic A 40926 |
| US6384013B1 (en) * | 1992-03-19 | 2002-05-07 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
| US5882900A (en) * | 1992-09-10 | 1999-03-16 | Gruppo Lepetit S.P.A. | Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium |
| CA2112776C (en) * | 1993-01-21 | 2002-11-12 | Masakazu Tsuchiya | Process for inhibiting activity of endotoxin |
| WO1994025588A2 (en) * | 1993-04-30 | 1994-11-10 | Biognostik Gesellschaft für Biomolekulare Diagnostik mbH | ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β) |
| SI9500039B (sl) * | 1995-02-07 | 2002-02-28 | Lek, | Nov kombiniran postopek čiščenja Vankomicin hidroklorida |
| KR100381688B1 (ko) * | 1995-02-07 | 2003-12-11 | 바이오써치 이탈리아 에스.피.에이. | Ge2270및ge2270-유사항생제의염기성프롤린-아미드유도체 |
| DK0808326T3 (da) * | 1995-02-07 | 2001-10-01 | Biosearch Italia Spa | Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika |
| US5789308A (en) * | 1995-06-06 | 1998-08-04 | Advanced Micro Devices, Inc. | Manufacturing method for wafer slice starting material to optimize extrinsic gettering during semiconductor fabrication |
| CA2180206A1 (en) * | 1995-06-30 | 1996-12-31 | Motoya Ohshika | Freeze-dried preparation for pharmaceutical use |
| CA2226142C (en) * | 1995-07-05 | 2007-11-13 | Gruppo Lepetit S.P.A. | Purification of dalbaheptide antibiotics by isoelectric focusing |
| DE19600590A1 (de) * | 1996-01-10 | 1997-07-24 | Tzn Forschung & Entwicklung | Schutzvorrichtung für optische Systeme zur Vermeidung von Schäden bei Bestrahlung dieser Systeme mit Laserlicht |
| EP0880541B1 (en) * | 1996-02-14 | 2003-01-15 | Biosearch Italia S.p.A. | Derivatives of antibiotic ge2270 factors |
| WO1997038702A1 (en) | 1996-04-12 | 1997-10-23 | Eli Lilly And Company | Covalently-linked glycopeptide dimers |
| KR20000010589A (ko) * | 1996-04-23 | 2000-02-15 | 클라우디오 쿼르타 | 항생제a40926의아미드유도체의개선된화학적제조방법 |
| US5935238A (en) * | 1997-06-19 | 1999-08-10 | Sun Microsystems, Inc. | Selection from multiple fetch addresses generated concurrently including predicted and actual target by control-flow instructions in current and previous instruction bundles |
| JP4204655B2 (ja) * | 1997-08-08 | 2009-01-07 | 株式会社ルネサステクノロジ | パルス出力機能付マイクロコンピュータ |
| CA2255140A1 (en) | 1997-12-23 | 1999-06-23 | Eli Lilly And Company | Echinocandin binding domain of 1,3-.beta.-glucan synthase |
| US6541616B1 (en) * | 1998-10-01 | 2003-04-01 | Antex Biologics Inc. | Moraxella catarrhalis protein, gene sequence and uses thereof |
| US6417180B1 (en) | 1998-10-07 | 2002-07-09 | University Of Massachusetts | Zinc finger-reactive antimicrobial compounds |
| IL140093A0 (en) * | 1998-12-23 | 2002-02-10 | Advanced Medicine Inc | Glycopeptide derivatives and pharmaceutical compositions containing the same |
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| AU2001259298A1 (en) | 2000-05-02 | 2001-11-12 | Advanced Medicine, Inc. | Polyacid glycopeptide derivatives |
| WO2003070756A2 (de) | 2002-02-18 | 2003-08-28 | Combinature Biopharm Ag | Neue glycopeptid-antibiotika und verfahren zu deren synthetisierung |
| DK1565201T3 (en) | 2002-11-18 | 2019-02-25 | Vicuron Pharmaceuticals Llc | METHODS OF ADMINISTRATING DALBAVANCIN TO TREAT Bacterial Infections |
| US7119061B2 (en) * | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
-
2003
- 2003-11-14 DK DK03789744.4T patent/DK1565201T3/en active
- 2003-11-14 WO PCT/US2003/036779 patent/WO2004045637A1/en not_active Ceased
- 2003-11-14 EP EP03789744.4A patent/EP1565201B1/en not_active Expired - Lifetime
- 2003-11-14 AU AU2003299561A patent/AU2003299561A1/en not_active Abandoned
- 2003-11-14 HU HUE03789744A patent/HUE041133T2/hu unknown
- 2003-11-14 ES ES03789744T patent/ES2712656T3/es not_active Expired - Lifetime
- 2003-11-14 KR KR1020057008951A patent/KR101173310B1/ko not_active Expired - Lifetime
- 2003-11-14 WO PCT/US2003/036399 patent/WO2004046196A2/en not_active Ceased
- 2003-11-14 KR KR1020127012832A patent/KR20120056310A/ko not_active Ceased
- 2003-11-14 PT PT03789744T patent/PT1565201T/pt unknown
- 2003-11-14 US US10/714,261 patent/US6900175B2/en active Active
- 2003-11-14 US US10/713,924 patent/US20050004011A1/en not_active Abandoned
- 2003-11-14 JP JP2004570384A patent/JP5519090B2/ja not_active Expired - Lifetime
- 2003-11-14 WO PCT/US2003/036127 patent/WO2004045636A1/en not_active Ceased
- 2003-11-14 MX MXPA05005338A patent/MXPA05005338A/es active IP Right Grant
- 2003-11-14 US US10/714,166 patent/US20050130909A1/en not_active Abandoned
- 2003-11-14 AU AU2003298662A patent/AU2003298662A1/en not_active Abandoned
- 2003-11-14 US US10/493,558 patent/US20050090433A1/en not_active Abandoned
- 2003-11-14 AU AU2003294262A patent/AU2003294262B2/en not_active Expired
- 2003-11-14 CA CA2506236A patent/CA2506236C/en not_active Expired - Lifetime
-
2004
- 2004-04-16 US US10/828,379 patent/US20040220122A1/en not_active Abandoned
- 2004-04-16 US US10/828,439 patent/US7115564B2/en not_active Expired - Lifetime
- 2004-04-16 US US10/828,483 patent/US20040198715A1/en not_active Abandoned
- 2004-04-20 US US10/829,068 patent/US20040224908A1/en not_active Abandoned
- 2004-09-15 US US10/942,197 patent/US20050032721A1/en not_active Abandoned
- 2004-09-15 US US10/942,604 patent/US20050130914A1/en not_active Abandoned
-
2005
- 2005-05-02 IL IL168327A patent/IL168327A/en active IP Right Grant
- 2005-05-12 NO NO20052362A patent/NO20052362L/no not_active Application Discontinuation
-
2009
- 2009-05-28 US US12/473,390 patent/US20090298748A1/en not_active Abandoned
- 2009-05-29 US US12/474,438 patent/US20090305953A1/en not_active Abandoned
-
2011
- 2011-04-05 JP JP2011083790A patent/JP2011157381A/ja active Pending
-
2013
- 2013-04-16 JP JP2013085785A patent/JP2013155188A/ja active Pending
-
2014
- 2014-02-06 IL IL230875A patent/IL230875A0/en unknown
-
2015
- 2015-07-13 IL IL239913A patent/IL239913B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013155188A5 (OSRAM) | ||
| HK1221646A1 (zh) | 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途 | |
| FI3494972T3 (fi) | Dolutegraviirin ja lamivudiinin yhdistelmiä hiv-infektion hoitoon | |
| JP2012193216A5 (OSRAM) | ||
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| PE20150161A1 (es) | Uso de laquinimod de dosis alta para el tratamiento de esclerosis multiple | |
| NZ714963A (en) | Compositions and methods for treating anemia | |
| MX2016011333A (es) | Sistemas de administracion de farmaco y metodo para el tratamiento de cancer de vejiga con gemcitabina. | |
| JP2015515985A5 (OSRAM) | ||
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| JP2013541583A5 (OSRAM) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| NZ700924A (en) | Dosage regimen for a pi-3 kinase inhibitor | |
| EA201501164A1 (ru) | Твердая фармацевтическая лекарственная форма | |
| MX2015016750A (es) | Composicion inmunogenica para uso en terapia. | |
| DK2802319T3 (da) | Fastdosiskombinationsterapi for parkinsons sygdom | |
| JP2017061488A5 (OSRAM) | ||
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. | |
| JP2016504361A5 (OSRAM) | ||
| TN2016000179A1 (en) | Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor. | |
| JP2013523789A5 (OSRAM) | ||
| JP2010519274A5 (OSRAM) | ||
| UA69674U (ru) | Способ лечения больных на эритематозно-бульозной рожей | |
| RU2023102211A (ru) | Схемы дозирования иммуноконъюгата anti-folr1 | |
| JP2015512439A5 (OSRAM) |